TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner

The HIV-1 capsid protein makes up the core of the virion and plays a critical role in early steps of HIV replication. Due to its exposure in the cytoplasm after entry, HIV capsid is a target for host cell factors that act directly to block infection such as TRIM5α and MxB. Several host proteins also play a role in facilitating infection, including in the protection of HIV-1 capsid from recognition by host cell restriction factors. Through an unbiased screening approach, called HIV-CRISPR, we show that the CPSF6-binding deficient, N74D HIV-1 capsid mutant is sensitive to restriction mediated by human TRIM34, a close paralog of the well-characterized HIV restriction factor TRIM5α. This restriction occurs at the step of reverse transcription, is independent of interferon stimulation, and limits HIV-1 infection in key target cells of HIV infection including CD4+ T cells and monocyte-derived dendritic cells. TRIM34 can also restrict some SIV capsids. TRIM34 restriction requires TRIM5α as knockout or knockdown of TRIM5α results in a loss of antiviral activity. Through immunofluorescence studies, we show that TRIM34 and TRIM5α colocalize to cytoplasmic bodies and are more frequently observed to be associated with infecting N74D capsids than with WT HIV-1 capsids. Our results identify TRIM34 as an HIV-1 CA-targeting restriction factor and highlight the potential role for heteromultimeric TRIM interactions in contributing to restriction of HIV-1 infection in human cells.

[1]  T. Hope,et al.  Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid , 2019, Journal of Virology.

[2]  O. Pornillos,et al.  Restriction of HIV-1 and other retroviruses by TRIM5 , 2019, Nature Reviews Microbiology.

[3]  M. Malim,et al.  Immunoproteasome activation enables human TRIM5α restriction of HIV-1 , 2019, Nature Microbiology.

[4]  Barbara Müller,et al.  HIV-1 nuclear import in macrophages is regulated by CPSF6-capsid interactions at the nuclear pore complex , 2019, eLife.

[5]  A. Brass,et al.  Capsid-CPSF6 Interaction Licenses Nuclear HIV-1 Trafficking to Sites of Viral DNA Integration. , 2018, Cell host & microbe.

[6]  P. Bieniasz,et al.  Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2 , 2018, eLife.

[7]  J. Delrow,et al.  A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV , 2018, bioRxiv.

[8]  A. Engelman,et al.  Capsid-Dependent Host Factors in HIV-1 Infection. , 2017, Trends in microbiology.

[9]  J. Luban,et al.  Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines , 2017, Nature Communications.

[10]  A. Engelman,et al.  Capsid-CPSF6 Interaction Is Dispensable for HIV-1 Replication in Primary Cells but Is Selected during Virus Passage In Vivo , 2016, Journal of Virology.

[11]  M. Malim,et al.  Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors , 2016, Journal of Virology.

[12]  A. Engelman,et al.  The Cleavage and Polyadenylation Specificity Factor 6 (CPSF6) Subunit of the Capsid-recruited Pre-messenger RNA Cleavage Factor I (CFIm) Complex Mediates HIV-1 Integration into Genes* , 2016, The Journal of Biological Chemistry.

[13]  A. Engelman,et al.  A critical role for alternative polyadenylation factor CPSF6 in targeting HIV-1 integration to transcriptionally active chromatin , 2016, Proceedings of the National Academy of Sciences.

[14]  T. Hope,et al.  HIV-1 capsid: the multifaceted key player in HIV-1 infection , 2015, Nature Reviews Microbiology.

[15]  L. James,et al.  HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry , 2015, Journal of Virology.

[16]  Zhenlong Liu,et al.  The highly polymorphic cyclophilin A-binding loop in HIV-1 capsid modulates viral resistance to MxB , 2015, Retrovirology.

[17]  Jun S. Liu,et al.  MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens , 2014, Genome Biology.

[18]  T. Hope,et al.  Identification of Capsid Mutations That Alter the Rate of HIV-1 Uncoating in Infected Cells , 2014, Journal of Virology.

[19]  P. Bieniasz,et al.  Host and Viral Determinants of Mx2 Antiretroviral Activity , 2014, Journal of Virology.

[20]  C. Aiken,et al.  HIV-1 uncoating: connection to nuclear entry and regulation by host proteins. , 2014, Virology.

[21]  G. Towers,et al.  A model for cofactor use during HIV-1 reverse transcription and nuclear entry☆ , 2014, Current opinion in virology.

[22]  D. Ivanov,et al.  Binding of the rhesus TRIM5α PRYSPRY domain to capsid is necessary but not sufficient for HIV-1 restriction. , 2014, Virology.

[23]  C. Aiken,et al.  In Vivo Functions of CPSF6 for HIV-1 as Revealed by HIV-1 Capsid Evolution in HLA-B27-Positive Subjects , 2014, PLoS pathogens.

[24]  L. James,et al.  HIV-1 evades innate immune recognition through specific co-factor recruitment , 2013, Nature.

[25]  Shilei Ding,et al.  The interferon-inducible MxB protein inhibits HIV-1 infection. , 2013, Cell host & microbe.

[26]  Charles M. Rice,et al.  MX2 is an interferon-induced inhibitor of HIV-1 infection , 2013, Nature.

[27]  M. Malim,et al.  Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection , 2013, Nature.

[28]  A. Engelman,et al.  The Host Proteins Transportin SR2/TNPO3 and Cyclophilin A Exert Opposing Effects on HIV-1 Uncoating , 2012, Journal of Virology.

[29]  Michael Emerman,et al.  Evolutionary conflicts between viruses and restriction factors shape immunity , 2012, Nature Reviews Immunology.

[30]  Torsten Schaller,et al.  CPSF6 Defines a Conserved Capsid Interface that Modulates HIV-1 Replication , 2012, PLoS pathogens.

[31]  M. Malim,et al.  HIV Restriction Factors and Mechanisms of Evasion. , 2012, Cold Spring Harbor perspectives in medicine.

[32]  A. Engelman,et al.  Human Immunodeficiency Virus Type 1 Capsid Mutation N74D Alters Cyclophilin A Dependence and Impairs Macrophage Infection , 2012, Journal of Virology.

[33]  J. Luban,et al.  Inhibition of HIV-1 infection by TNPO3 depletion is determined by capsid and detectable after viral cDNA enters the nucleus , 2011, Retrovirology.

[34]  Mahdad Noursadeghi,et al.  HIV-1 Capsid-Cyclophilin Interactions Determine Nuclear Import Pathway, Integration Targeting and Replication Efficiency , 2011, PLoS pathogens.

[35]  B. Sobhian,et al.  SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx , 2011, Nature.

[36]  M. Washburn,et al.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein , 2011, Nature.

[37]  J. Sodroski,et al.  Determinants of the Higher Order Association of the Restriction Factor TRIM5α and Other Tripartite Motif (TRIM) Proteins* , 2011, The Journal of Biological Chemistry.

[38]  Jeremy Luban,et al.  TRIM5 is an innate immune sensor for the retrovirus capsid lattice , 2011, Nature.

[39]  J. Nieman,et al.  HIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention , 2010, PLoS pathogens.

[40]  R. Schooley,et al.  Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial. , 2010, The Journal of infectious diseases.

[41]  A. Engelman,et al.  Flexible use of nuclear import pathways by HIV-1. , 2010, Cell host & microbe.

[42]  Michael Emerman,et al.  Discordant Evolution of the Adjacent Antiretroviral Genes TRIM22 and TRIM5 in Mammals , 2007, PLoS pathogens.

[43]  J. Sodroski,et al.  Unique features of TRIM5α among closely related human TRIM family members , 2007 .

[44]  P. Bieniasz,et al.  Generation of Simian-Tropic HIV-1 by Restriction Factor Evasion , 2006, Science.

[45]  D. Pérez-Caballero,et al.  Antiretroviral potential of human tripartite motif-5 and related proteins. , 2006, Virology.

[46]  S. Nisole,et al.  TRIM family proteins: retroviral restriction and antiviral defence , 2005, Nature Reviews Microbiology.

[47]  Michael Emerman,et al.  Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Emerman,et al.  Capsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells , 2004, Journal of Virology.

[49]  R. König,et al.  Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif , 2003, Cell.

[50]  A Orimo,et al.  Molecular cloning of ring finger protein 21 (RNF21)/interferon-responsive finger protein (ifp1), which possesses two RING-B box-coiled coil domains in tandem. , 2000, Genomics.

[51]  J. Lisziewicz,et al.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.

[52]  Jeremy Luban,et al.  Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B , 1993, Cell.

[53]  T. Sultana,et al.  Multiple pathways to avoid IFN-β sensitivity of HIV-1 by mutations in capsid , 2019 .

[54]  J. Sodroski,et al.  Unique features of TRIM5alpha among closely related human TRIM family members. , 2007, Virology.